Prognostic factors affecting survival in children and adolescents with HIV and Hodgkin lymphoma in South Africa.
Jennifer Ann GeelKatherine Claire EyalMarc Gerald HendricksKhumo Hope MyezoDavid Kenneth StonesFareed OmarYasmin GogaAnel Van ZylBarry van EmmenesManickavallie VaithilingumShaegan IrusenRossella Marina BandiniOloko WediBiance RoweDaynia Elizabeth BallotMonika L Metzgernull nullPublished in: Leukemia & lymphoma (2020)
South African children with Hodgkin lymphoma (HL) and human immunodeficiency virus (HIV) have low 5-year overall survival (OS) rates. In this retrospective multicenter study, 271 South African pediatric patients with HL were studied to determine OS and prognostic factors in those with HIV and HL. Univariate risk factor analysis was performed to analyze prognostic factors. The 29 HIV-infected patients were younger (p = .021), more likely to present with wasting (0.0573), stunting (0.0332), and Stage IV disease (p = .000) than HIV-uninfected patients. The 5- and 10-year OS of HIV-infected patients of 49% and 45% versus 84% and 79%, respectively for HIV-uninfected patients (p = .0001) appeared to be associated with hypoalbuminemia (<20 g/dL) and CD4 percentage of <15%. Causes of death in the HIV-infected group included disease progression (6/14), infection (4/14), unknown (3/14), and second malignancy (1/14). HIV-infected pediatric patients with HL experience increased mortality due to post-therapy opportunistic and nosocomial infections.
Keyphrases
- antiretroviral therapy
- hiv infected
- hiv infected patients
- human immunodeficiency virus
- prognostic factors
- hiv positive
- hiv aids
- hodgkin lymphoma
- end stage renal disease
- south africa
- chronic kidney disease
- risk factors
- hepatitis c virus
- hiv testing
- cardiovascular disease
- type diabetes
- young adults
- newly diagnosed
- cross sectional
- patient reported outcomes
- mesenchymal stem cells
- staphylococcus aureus